FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Ajanta Pharma Fluphenazine Hydrochloride Tablets Recall

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by:…

Ajanta Pharma USA Inc · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Sep 16, 2026
Recall ID
D-0836-2026
Check your lot numberHow we source this data

Summary

Ajanta Pharma recalled Fluphenazine Hydrochloride Tablets starting Aug 25, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0836-2026 on Sep 16, 2026. Reason: Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent. Status: Ongoing.

Why it was recalled

Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

Product description

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.

Lot numbers, UPCs & expiration codes

Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027.

Where it was sold

Nationwide within the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0836-2026
Classification
Class III
Status
Ongoing
Recall initiated
Aug 25, 2026
FDA report date
Sep 16, 2026
Quantity
403,200 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Ajanta Pharma USA Inc

Original FDA data

Every field from FDA enforcement report D-0836-2026, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
99733
Address
400 Crossing Blvd Ste 102
Code information
Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027.
Postal code
08807-2863
Report date
Sep 16, 2026
Product type
Drugs
Recall number
D-0836-2026
Classification
Class III
Recalling firm
Ajanta Pharma USA Inc
Product quantity
403,200 tablets
Reason for recall
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.
Distribution pattern
Nationwide within the U.S
Recall initiation date
Aug 25, 2026
Initial firm notification
Letter
Center classification date
Sep 8, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0836-2026, published Sep 16, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls